⟵ Back to Search Results

BGB-290-202

Terminated

Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency

Beigene Study ID info

BGB-290-202

ClinicalTrials.gov ID info

NCT03712930

EudraCT Number info

2018-002587-28

Study Overview

Sex: Male

Age: 18 Years and older   (Adult, Older Adult)

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: Male

Age: 18 Years and older   (Adult, Older Adult)

Study Documents

Study Protocol Statistical Analysis Plan